3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
3
Triple Negative Breast Neoplasms
1
Bulbo-Spinal Atrophy, X-Linked
1
Interventions
enzalutamide
2
ostarine
1
nilutamide
1
exemestane
1
bicalutamide
1
apalutamide
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Bulbo-Spinal Atrophy, X-Linked
×
ostarine
×
Clear all
NCT04869943
2024-01-26
ARTEST
Veru Inc.
Phase 3
Terminated
52 enrolled